Kinetic scheduling of vincristine (NSC-67574) and bleomycin (NSC-125066) in patients with lung cancer and other malignant tumors
Livingston, R.B.; Bodey, G.P.; Gottlieb, J.A.; Frei, E.
Cancer ChemoTherapy Reports 57(2): 219-224
1973
ISSN/ISBN: 0069-0112 PMID: 4126382 Document Number: 59245
Document emailed within 1 workday
Related Documents
Dudareva, L.A. 1990: The combined chemotherapy with vincristine, prospidin, bleomycin and cyclophosphane of epidermoid lung cancer Voprosy Onkologii 36(9): 1092-1095Huang, H.; Lian, L.; Huang, R. 1995: Response of ovarian endodermal sinus tumor to combination chemotherapy with cis-platinum, vincristine and bleomycin or vincristine, actinomycin and cyclophosphamide Zhonghua Fu Chan Ke Za Zhi 30(5): 265-269
Abad-Esteve, A.; Rosell, R.; Moreno, I.; Fernández-Marcial, C.; Roselló, M.; Ribas Mundó, M. 1988: VP-16, vincristine, adriamycin and cyclophosphamide (EVAC) in patients with small-cell lung cancer Medicina Clinica 90(14): 569-572
Shimizu, Y.; Nakayama, K.; Seimiya, Y.; Yamakawa, Y.; Koi, S.; Yokosuka, K.; Teshima, H.; Chen, J.T.; Fujimoto, I.; Yamauchi, K. 1991: Treatment of advanced or recurrent cervical cancer by a new BOMP regimen consisting of bleomycin, vincristine, mitomycin-C, and low-dose consecutive cisplatin Nihon Sanka Fujinka Gakkai Zasshi 43(5): 549-556
Hayakawa, K.; Mitsuhashi, N.; Tamaki, Y.; Nakajima, N.; Nakayama, Y.; Niibe, H. 1989: Double primary malignant tumors involving a lung cancer Gan no Rinsho. Japan Journal of Cancer Clinics 35(5): 560-563
Samson, M.K.; Baker, L.H.; Fraile, R.J.; Izbicki, R.M.; Vaitkevicius, V.K. 1977: Combination chemotherapy with cyclophosphamide, vincristine, methyl-CCNU, and bleomycin in advanced bronchogenic carcinoma: experience with 106 patients Cancer Treatment Reports 61(1): 59-64
Stasler, B.; Szepesi, T.; Holmann, K.; Kühböck, J.; Mailath, G.; Honenberg, G. 1989: Simultaneous radiation- and chemotherapy (methotrexate and bleomycin) of inoperable malignant oro-facial tumors Fogorvosi Szemle 82(7): 211-217
Bernstein, I.D.; Evans, A.E.; Finklestein, J.; Klemperer, M.; Hittle, R.; Leikin, S.; Hammond, G.D. 1978: Phase II study of the failure of vincristine and bleomycin for previously treated children with metastatic neuroblastoma: a report from the Childrens Cancer Study Group Cancer Treatment Reports 62(8): 1201-1202
Grigor'eva, S.P.; Dobrovol'skiĭ, S.R. 1985: Surgery of malignant tumors of the lung in patients with diabetes mellitus Grudnaia Khirurgiia 4: 23-26
Ishii, K.; Yamamoto, Y.; Shigeki, T.; Kitayama, H.; Hayashi, K.; Hirose, A.; Ohta, T.; Mugitani, A.; Fujino, H.; Yagi, T.; Hirai, M.; Teshima, H.; Katsurada, T.; Urase, F.; Kitajima, H. 2005: VNCOP-B (etoposide, mitoxantrone, cyclophosphamide, vincristine, predonisolone, bleomycin) therapy in elderly patients with aggressive non-Hodgkin lymphoma--a study of efficacy and safety, final report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(1): 39-44
Houghton, J.A.; Meyer, W.H.; Houghton, P.J. 1987: Scheduling of vincristine: drug accumulation and response of xenografts of childhood rhabdomyosarcoma determined by frequency of administration Cancer Treatment Reports 71(7-8): 717-721
Lazo, J.S.; Chen, D.L.; Gallicchio, V.S.; Hait, W.N. 1986: Increased lethality of calmodulin antagonists and bleomycin to human bone marrow and bleomycin-resistant malignant cells Cancer Research 46(5): 2236-2240
Schubert, W.; Awissus, B.; Mehnert, W.H.; Wunderlich, P. 1990: Malignant tumors of the lung and bronchi in children and adolescents. 2. Analysis of 66 cases of the East German National Cancer Registry (1961-1985) Kinderarztliche Praxis 58(2): 73-77
Kamata, H.; Asano, K.; Soejima, K.; Shirahata, T.; Nakatani, M.; Inamoto, H.; Iketani, O.; Yamayoshi, Y.; Tanigawara, Y.; Ishizaka, A. 2009: Appropriate hemodialysis scheduling based on therapeutic drug monitoring of carboplatin in a patient with lung cancer and chronic renal failure Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(9): 1529-1532
Trush, M.A.; Mimnaugh, E.G.; Ginsburg, E.; Gram, T.E. 1982: Studies on the interaction of bleomycin A2 with rat lung microsomes. I. Characterization of factors which influence bleomycin-mediated DNA chain breakage Journal of Pharmacology and Experimental Therapeutics 221(1): 152-158
Giovagnoli, M.R.; Gallo, G.; Colelli, F.; Vecchione, A.; Bononi, M. 2002: Aspiration cytology of malignant hemangiopericytoma metastatic to the lung in a patient with previous primary malignant tumors: differential diagnosis Acta Cytologica 46(2): 430-432
Trush, M.A.; Mimnaugh, E.G.; Ginsburg, E.; Gram, T.E. 1982: Studies on the interaction of bleomycin A2 with rat lung microsomes. II. Involvement of adventitious iron and reactive oxygen in bleomycin-mediated DNA chain breakage Journal of Pharmacology and Experimental Therapeutics 221(1): 159-165
Lorigan, P.; Lee, S.M.; Betticher, D.; Woodhead, M.; Weir, D.; Hanley, S.; Hardy, C.; Thatcher, N. 1995: Chemotherapy with vincristine/ifosfamide/carboplatin/etoposide in small cell lung cancer Seminars in Oncology 22(3 Suppl 7: 32-41
Wheeler, R.H.; Liepman, M.K.; Baker, S.R.; Earhart, R.H.; Bull, F.E.; Ensminger, W.D. 1980: Bleomycin, vincristine, and mitomycin C with or without methotrexate in the treatment of squamous cell carcinoma Cancer Treatment Reports 64(8-9): 943-949
Unsal, M.; Erturk, D. 2003: Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer Saudi Medical Journal 24(6): 628-631